Product Information
TRIAZOLAM 0.125 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3397 per EA under NDC 59762371709. Its NADAC has been published 484 times since Mar 22, 2017.
Strength
.125 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762371709
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TRIAZOLAMApproval Type
Authorized Generic (NDA)
FDA Application
NDA017892On Market Since
11/15/1982
Pharmacological Classes
Price Statistics
The NADAC for TRIAZOLAM 0.125 MG TABLET has been published 484 times since Mar 22, 2017, and over the history we have for it it has declined 74.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3397 per EA |
|---|---|
| All-time high | $1.7887 (May 13, 2020) |
| All-time low | $0.2219 (Jan 22, 2025) |
| 52-week high | $0.3975 |
| 52-week low | $0.3206 |
| Median price | $1.1602 |
| Average price | $1.0352 |
| Largest weekly change | +49.3% (Mar 23, 2022) |
| Weeks tracked | 484 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the triazolam market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TRIAZOLAM 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIAZOLAM 0.125 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3397 per EA (NDC 59762371709), effective Jun 24, 2026.
How has the price of TRIAZOLAM 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIAZOLAM 0.125 MG TABLET has declined 74.0%. It has been tracked across 484 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for TRIAZOLAM 0.125 MG TABLET?
Since Mar 22, 2017, the NADAC for TRIAZOLAM 0.125 MG TABLET has ranged from a low of $0.2219 (Jan 22, 2025) to a high of $1.7887 (May 13, 2020), with a median of $1.1602 per EA.
Are there cheaper alternatives to TRIAZOLAM 0.125 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TRIAZOLAM 0.125 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures TRIAZOLAM 0.125 MG TABLET?
TRIAZOLAM 0.125 MG TABLET (NDC 59762371709) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification